Geode Capital Management’s Aligos Therapeutics ALGS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $246K | Buy |
34,048
+5,978
| +21% | +$43.1K | ﹤0.01% | 3806 |
|
|
2025
Q1 | $232K | Buy |
28,070
+817
| +3% | +$6.74K | ﹤0.01% | 3791 |
|
|
2024
Q4 | $1.09M | Buy |
27,253
+3,197
| +13% | +$127K | ﹤0.01% | 3344 |
|
|
2024
Q3 | $208K | Sell |
24,056
-381,638
| -94% | -$3.31M | ﹤0.01% | 3890 |
|
|
2024
Q2 | $142K | Buy |
405,694
+32,638
| +9% | +$11.4K | ﹤0.01% | 4029 |
|
|
2024
Q1 | $366K | Buy |
373,056
+52,012
| +16% | +$51K | ﹤0.01% | 3722 |
|
|
2023
Q4 | $213K | Buy |
321,044
+79,541
| +33% | +$52.8K | ﹤0.01% | 3918 |
|
|
2023
Q3 | $180K | Sell |
241,503
-15,089
| -6% | -$11.3K | ﹤0.01% | 4023 |
|
|
2023
Q2 | $249K | Buy |
256,592
+56,734
| +28% | +$55.1K | ﹤0.01% | 3945 |
|
|
2023
Q1 | $175K | Hold |
199,858
| – | – | ﹤0.01% | 4118 |
|
|
2022
Q4 | $190K | Buy |
199,858
+9,440
| +5% | +$8.97K | ﹤0.01% | 4128 |
|
|
2022
Q3 | $209K | Hold |
190,418
| – | – | ﹤0.01% | 4184 |
|
|
2022
Q2 | $230K | Sell |
190,418
-164,369
| -46% | -$199K | ﹤0.01% | 4175 |
|
|
2022
Q1 | $762K | Buy |
354,787
+5,211
| +1% | +$11.2K | ﹤0.01% | 3732 |
|
|
2021
Q4 | $4.15M | Buy |
349,576
+35,921
| +11% | +$426K | ﹤0.01% | 2997 |
|
|
2021
Q3 | $4.86M | Buy |
313,655
+58,307
| +23% | +$904K | ﹤0.01% | 2926 |
|
|
2021
Q2 | $5.21M | Buy |
255,348
+76,596
| +43% | +$1.56M | ﹤0.01% | 2873 |
|
|
2021
Q1 | $4.06M | Buy |
178,752
+58
| +0% | +$1.32K | ﹤0.01% | 2891 |
|
|
2020
Q4 | $4.94M | Buy |
+178,694
| New | +$4.94M | ﹤0.01% | 2611 |
|